ABSI
Price
$4.07
Change
+$0.28 (+7.39%)
Updated
Oct 11 closing price
24 days until earnings call
PRME
Price
$3.64
Change
+$0.06 (+1.68%)
Updated
Oct 11 closing price
19 days until earnings call
Ad is loading...

ABSI vs PRME

Header iconABSI vs PRME Comparison
Open Charts ABSI vs PRMEBanner chart's image
Absci
Price$4.07
Change+$0.28 (+7.39%)
Volume$1.18M
CapitalizationN/A
Prime Medicine
Price$3.64
Change+$0.06 (+1.68%)
Volume$1.07M
CapitalizationN/A
View a ticker or compare two or three
ABSI vs PRME Comparison Chart
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ABSI vs. PRME commentary
Oct 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a StrongBuy and PRME is a Buy.

COMPARISON
Comparison
Oct 13, 2024
Stock price -- (ABSI: $4.07 vs. PRME: $3.64)
Brand notoriety: ABSI and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 132% vs. PRME: 68%
Market capitalization -- ABSI: $433.79M vs. PRME: $415.31M
ABSI [@Biotechnology] is valued at $433.79M. PRME’s [@Biotechnology] market capitalization is $415.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, ABSI is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 6 TA indicator(s) are bullish while PRME’s TA Score has 5 bullish TA indicator(s).

  • ABSI’s TA Score: 6 bullish, 2 bearish.
  • PRME’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, ABSI is a better buy in the short-term than PRME.

Price Growth

ABSI (@Biotechnology) experienced а +4.90% price change this week, while PRME (@Biotechnology) price change was +3.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

ABSI is expected to report earnings on Mar 19, 2025.

PRME is expected to report earnings on Nov 01, 2024.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($434M) and PRME($415M) have the same market capitalization . ABSI YTD gains are higher at: -3.095 vs. PRME (-58.916). ABSI has higher annual earnings (EBITDA): -77.61M vs. PRME (-204.68M). PRME has more cash in the bank: 163M vs. ABSI (145M). ABSI has less debt than PRME: ABSI (13.3M) vs PRME (41.6M). ABSI has higher revenues than PRME: ABSI (3.25M) vs PRME (591K).
ABSIPRMEABSI / PRME
Capitalization434M415M105%
EBITDA-77.61M-204.68M38%
Gain YTD-3.095-58.9165%
P/E RatioN/AN/A-
Revenue3.25M591K550%
Total Cash145M163M89%
Total Debt13.3M41.6M32%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSIPRME
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
89%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
88%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X63193.023000747.933600
+1.20%
Bitcoin cryptocurrency
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with PLRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
+7.39%
PLRX - ABSI
49%
Loosely correlated
+17.67%
NTLA - ABSI
48%
Loosely correlated
+4.44%
MDXG - ABSI
47%
Loosely correlated
+3.63%
RXRX - ABSI
47%
Loosely correlated
+7.12%
PRME - ABSI
46%
Loosely correlated
+1.68%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been closely correlated with NTLA. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if PRME jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+1.68%
NTLA - PRME
67%
Closely correlated
+4.44%
BEAM - PRME
64%
Loosely correlated
+7.34%
ABCL - PRME
58%
Loosely correlated
+3.60%
CRSP - PRME
57%
Loosely correlated
+3.22%
RXRX - PRME
55%
Loosely correlated
+7.12%
More